{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:14:46Z","timestamp":1764080086787,"version":"3.30.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-80138-2","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T11:11:17Z","timestamp":1733224277000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Causal relationship between inflammatory proteins, immune cells, and gout: a Mendelian randomization study"],"prefix":"10.1038","volume":"14","author":[{"given":"Rui","family":"Lai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinmin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumei","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,3]]},"reference":[{"issue":"7","key":"80138_CR1","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s41584-020-0441-1","volume":"16","author":"M Dehlin","year":"2020","unstructured":"Dehlin, M., Jacobsson, L. & Roddy, E. Global epidemiology of gout: Prevalence, incidence, treatment patterns and risk factors. Nat. Rev. Rheumatol. 16(7), 380\u2013390. https:\/\/doi.org\/10.1038\/s41584-020-0441-1 (2020).","journal-title":"Nat. Rev. Rheumatol."},{"issue":"3","key":"80138_CR2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1024\/0040-5930\/a000767","volume":"73","author":"B Ankli","year":"2016","unstructured":"Ankli, B. Current epidemiology of gout. Ther. Umsch. 73(3), 125\u2013129. https:\/\/doi.org\/10.1024\/0040-5930\/a000767 (2016).","journal-title":"Ther. Umsch."},{"key":"80138_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jare.2022.11.003","volume":"52","author":"R Wang","year":"2023","unstructured":"Wang, R. et al. Sulforaphane-driven reprogramming of gut microbiome and metabolome ameliorates the progression of hyperuricemia. J. Adv. Res. 52, 19\u201328. https:\/\/doi.org\/10.1016\/j.jare.2022.11.003 (2023).","journal-title":"J. Adv. Res."},{"issue":"4","key":"80138_CR4","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s10067-019-04868-9","volume":"39","author":"C Mattiuzzi","year":"2020","unstructured":"Mattiuzzi, C. & Lippi, G. Recent updates on worldwide gout epidemiology. Clin. Rheumatol. 39(4), 1061\u20131063. https:\/\/doi.org\/10.1007\/s10067-019-04868-9 (2020).","journal-title":"Clin. Rheumatol."},{"issue":"10","key":"80138_CR5","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s40273-015-0288-5","volume":"33","author":"GE Shields","year":"2015","unstructured":"Shields, G. E. & Beard, S. M. A systematic review of the economic and humanistic burden of gout. Pharmacoeconomics 33(10), 1029\u20131047. https:\/\/doi.org\/10.1007\/s40273-015-0288-5 (2015).","journal-title":"Pharmacoeconomics"},{"issue":"7","key":"80138_CR6","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1185\/030079906X112606","volume":"22","author":"RA Brook","year":"2006","unstructured":"Brook, R. A. et al. The economic burden of gout on an employed population. Curr. Med. Res. Opin. 22(7), 1381\u20131389 (2006).","journal-title":"Curr. Med. Res. Opin."},{"key":"80138_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.curtheres.2013.04.003","volume":"75","author":"A Wertheimer","year":"2013","unstructured":"Wertheimer, A., Morlock, R. & Becker, M. A. A revised estimate of the burden of illness of gout. Curr. Ther. Res. Clin. Exp. 75, 1\u20134. https:\/\/doi.org\/10.1016\/j.curtheres.2013.04.003 (2013).","journal-title":"Curr. Ther. Res. Clin. Exp."},{"issue":"10","key":"80138_CR8","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1007\/s10067-020-05090-8","volume":"39","author":"M Wu","year":"2020","unstructured":"Wu, M., Tian, Y., Wang, Q. & Guo, C. Gout: A disease involved with complicated immunoinflammatory responses: A narrative review. Clin. Rheumatol. 39(10), 2849\u20132859. https:\/\/doi.org\/10.1007\/s10067-020-05090-8 (2020).","journal-title":"Clin. Rheumatol."},{"issue":"2","key":"80138_CR9","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/ar2952","volume":"12","author":"N Busso","year":"2010","unstructured":"Busso, N. & So, A. Mechanisms of inflammation in gout. Arthritis Res. Ther. 12(2), 206. https:\/\/doi.org\/10.1186\/ar2952 (2010).","journal-title":"Arthritis Res. Ther."},{"issue":"11","key":"80138_CR10","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nrrheum.2017.155","volume":"13","author":"AK So","year":"2017","unstructured":"So, A. K. & Martinon, F. Inflammation in gout: Mechanisms and therapeutic targets. Nat. Rev. Rheumatol. 13(11), 639\u2013647. https:\/\/doi.org\/10.1038\/nrrheum.2017.155 (2017).","journal-title":"Nat. Rev. Rheumatol."},{"key":"80138_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110466","volume":"121","author":"W Liu","year":"2023","unstructured":"Liu, W. et al. Immune and inflammatory mechanisms and therapeutic targets of gout: An update. Int. Immunopharmacol. 121, 110466. https:\/\/doi.org\/10.1016\/j.intimp.2023.110466 (2023).","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"80138_CR12","doi-asserted-by":"publisher","first-page":"140","DOI":"10.4078\/jrd.2022.29.3.140","volume":"29","author":"S-K Kim","year":"2022","unstructured":"Kim, S.-K. The mechanism of the NLRP3 inflammasome activation and pathogenic implication in the pathogenesis of gout. J. Rheum. Dis. 29(3), 140\u2013153. https:\/\/doi.org\/10.4078\/jrd.2022.29.3.140 (2022).","journal-title":"J. Rheum. Dis."},{"key":"80138_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.888306","volume":"13","author":"J Zhao","year":"2022","unstructured":"Zhao, J. et al. Inflammatory response to regulated cell death in gout and its functional implications. Front. Immunol. 13, 888306. https:\/\/doi.org\/10.3389\/fimmu.2022.888306 (2022).","journal-title":"Front. Immunol."},{"issue":"4","key":"80138_CR14","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/jrsm.1346","volume":"10","author":"J Bowden","year":"2019","unstructured":"Bowden, J. & Holmes, M. V. Meta-analysis and mendelian randomization: A review. Res. Synth. Methods 10(4), 486\u2013496. https:\/\/doi.org\/10.1002\/jrsm.1346 (2019).","journal-title":"Res. Synth. Methods"},{"issue":"R1","key":"80138_CR15","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","volume":"23","author":"G Davey Smith","year":"2014","unstructured":"Davey Smith, G. & Hemani, G. Mendelian randomization: Genetic anchors for causal inference in epidemiological studies. Hum. Mol. Genet. 23(R1), R89\u2013R98. https:\/\/doi.org\/10.1093\/hmg\/ddu328 (2014).","journal-title":"Hum. Mol. Genet."},{"issue":"16","key":"80138_CR16","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","volume":"326","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova, V. W. et al. Strengthening the reporting of observational studies in epidemiology using mendelian randomization: The STROBE-MR statement. JAMA 326(16), 1614\u20131621. https:\/\/doi.org\/10.1001\/jama.2021.18236 (2021).","journal-title":"JAMA"},{"issue":"9","key":"80138_CR17","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/s41590-023-01588-w","volume":"24","author":"JH Zhao","year":"2023","unstructured":"Zhao, J. H. et al. Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets. Nat. Immunol. 24(9), 1540\u20131551. https:\/\/doi.org\/10.1038\/s41590-023-01588-w (2023).","journal-title":"Nat. Immunol."},{"issue":"10","key":"80138_CR18","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","volume":"52","author":"V Orr\u00f9","year":"2020","unstructured":"Orr\u00f9, V. et al. Complex genetic signatures in immune cells underlie autoimmunity and inform therapy. Nat. Genet. 52(10), 1036\u20131045. https:\/\/doi.org\/10.1038\/s41588-020-0684-4 (2020).","journal-title":"Nat. Genet."},{"issue":"4","key":"80138_CR19","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s40471-017-0128-6","volume":"4","author":"J Zheng","year":"2017","unstructured":"Zheng, J. et al. Recent developments in mendelian randomization studies. Curr. Epidemiol. Rep. 4(4), 330\u2013345. https:\/\/doi.org\/10.1007\/s40471-017-0128-6 (2017).","journal-title":"Curr. Epidemiol. Rep."},{"issue":"12","key":"80138_CR20","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/j.joca.2021.08.003","volume":"29","author":"XH Yu","year":"2021","unstructured":"Yu, X. H., Yang, Y. Q., Cao, R. R., Bo, L. & Lei, S. F. The causal role of gut microbiota in development of osteoarthritis. Osteoarthr. Cartil. 29(12), 1741\u20131750. https:\/\/doi.org\/10.1016\/j.joca.2021.08.003 (2021).","journal-title":"Osteoarthr. Cartil."},{"key":"80138_CR21","doi-asserted-by":"publisher","first-page":"1332383","DOI":"10.3389\/fendo.2023.1332383","volume":"14","author":"R Lai","year":"2023","unstructured":"Lai, R. et al. The causal relationship between 41 inflammatory cytokines and hypothyroidism: Bidirectional two-sample Mendelian randomization study. Front. Endocrinol. 14, 1332383. https:\/\/doi.org\/10.3389\/fendo.2023.1332383 (2023).","journal-title":"Front. Endocrinol."},{"issue":"5","key":"80138_CR22","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck, M., Chen, C.-Y., Neale, B. & Do, R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat. Genet. 50(5), 693\u2013698. https:\/\/doi.org\/10.1038\/s41588-018-0099-7 (2018).","journal-title":"Nat. Genet."},{"issue":"3","key":"80138_CR23","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ije\/dyr036","volume":"40","author":"S Burgess","year":"2011","unstructured":"Burgess, S. & Thompson, S. G. Avoiding bias from weak instruments in Mendelian randomization studies. Int. J. Epidemiol. 40(3), 755\u2013764. https:\/\/doi.org\/10.1093\/ije\/dyr036 (2011).","journal-title":"Int. J. Epidemiol."},{"issue":"7","key":"80138_CR24","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess, S., Butterworth, A. & Thompson, S. G. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet. Epidemiol. 37(7), 658\u2013665. https:\/\/doi.org\/10.1002\/gepi.21758 (2013).","journal-title":"Genet. Epidemiol."},{"issue":"6","key":"80138_CR25","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1093\/ije\/dyw220","volume":"45","author":"J Bowden","year":"2016","unstructured":"Bowden, J. et al. Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: The role of the I2 statistic. Int. J. Epidemiol. 45(6), 1961\u20131974. https:\/\/doi.org\/10.1093\/ije\/dyw220 (2016).","journal-title":"Int. J. Epidemiol."},{"issue":"4","key":"80138_CR26","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden, J., Davey Smith, G., Haycock, P. C. & Burgess, S. Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator. Genet. Epidemiol. 40(4), 304\u2013314. https:\/\/doi.org\/10.1002\/gepi.21965 (2016).","journal-title":"Genet. Epidemiol."},{"issue":"5","key":"80138_CR27","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","volume":"32","author":"S Burgess","year":"2017","unstructured":"Burgess, S. & Thompson, S. G. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur. J. Epidemiol. 32(5), 377\u2013389. https:\/\/doi.org\/10.1007\/s10654-017-0255-x (2017).","journal-title":"Eur. J. Epidemiol."},{"key":"80138_CR28","doi-asserted-by":"publisher","first-page":"31082","DOI":"10.1038\/srep31082","volume":"6","author":"L Han","year":"2016","unstructured":"Han, L. et al. Epidermal growth factor gene is a newly identified candidate gene for gout. Sci. Rep. 6, 31082. https:\/\/doi.org\/10.1038\/srep31082 (2016).","journal-title":"Sci. Rep."},{"key":"80138_CR29","doi-asserted-by":"publisher","first-page":"94","DOI":"10.2174\/1874312901812010094","volume":"12","author":"W Zhu","year":"2018","unstructured":"Zhu, W., Deng, Y. & Zhou, X. Multiple membrane transporters and some immune regulatory genes are major genetic factors to gout. Open Rheumatol. J. 12, 94. https:\/\/doi.org\/10.2174\/1874312901812010094 (2018).","journal-title":"Open Rheumatol. J."},{"issue":"5","key":"80138_CR30","doi-asserted-by":"publisher","first-page":"R210","DOI":"10.1186\/ar4048","volume":"14","author":"HS Kim","year":"2012","unstructured":"Kim, H. S. & Chung, D. H. TLR4-mediated IL-12 production enhances IFN-\u03b3 and IL-1\u03b2 production, which inhibits TGF-\u03b2 production and promotes antibody-induced joint inflammation. Arthritis Res. Ther. 14(5), R210. https:\/\/doi.org\/10.1186\/ar4048 (2012).","journal-title":"Arthritis Res. Ther."},{"issue":"5","key":"80138_CR31","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.7150\/thno.40650","volume":"10","author":"A Mariotte","year":"2020","unstructured":"Mariotte, A. et al. A mouse model of MSU-induced acute inflammation in vivo suggests imiquimod-dependent targeting of Il-1\u03b2 as relevant therapy for gout patients. Theranostics 10(5), 2158\u20132171. https:\/\/doi.org\/10.7150\/thno.40650 (2020).","journal-title":"Theranostics"},{"issue":"6","key":"80138_CR32","doi-asserted-by":"publisher","first-page":"322","DOI":"10.4110\/in.2016.16.6.322","volume":"16","author":"GH Lee","year":"2016","unstructured":"Lee, G. H. & Lee, W.-W. Unusual CD4+CD28- T cells and their pathogenic role in chronic inflammatory disorders. Immune Netw. 16(6), 322\u2013329. https:\/\/doi.org\/10.4110\/in.2016.16.6.322 (2016).","journal-title":"Immune Netw."},{"key":"80138_CR33","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3389\/fimmu.2017.00727","volume":"8","author":"H Zhao","year":"2017","unstructured":"Zhao, H., Bo, C., Kang, Y. & Li, H. What else can CD39 tell us?. Front. Immunol. 8, 727. https:\/\/doi.org\/10.3389\/fimmu.2017.00727 (2017).","journal-title":"Front. Immunol."},{"issue":"2","key":"80138_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002028","volume":"7","author":"FE Leal","year":"2013","unstructured":"Leal, F. E. et al. Expansion in CD39\u207a CD4\u207a immunoregulatory t cells and rarity of Th17 cells in HTLV-1 infected patients is associated with neurological complications. PLoS Negl. Trop. Dis. 7(2), e2028. https:\/\/doi.org\/10.1371\/journal.pntd.0002028 (2013).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"80138_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.567472","volume":"11","author":"J Libera","year":"2020","unstructured":"Libera, J. et al. Decreased frequency of intestinal CD39+ \u03b3\u03b4+ T cells with tissue-resident memory phenotype in inflammatory bowel disease. Front. Immunol. 11, 567472. https:\/\/doi.org\/10.3389\/fimmu.2020.567472 (2020).","journal-title":"Front. Immunol."},{"issue":"1","key":"80138_CR36","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/eji.200939258","volume":"40","author":"LC Ndhlovu","year":"2010","unstructured":"Ndhlovu, L. C. et al. A novel human CD4+ T-cell inducer subset with potent immunostimulatory properties. Eur. J. Immunol. 40(1), 134\u2013141. https:\/\/doi.org\/10.1002\/eji.200939258 (2010).","journal-title":"Eur. J. Immunol."},{"key":"80138_CR37","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","volume":"7","author":"TR Mosmann","year":"1989","unstructured":"Mosmann, T. R. & Coffman, R. L. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145\u2013173 (1989).","journal-title":"Annu. Rev. Immunol."},{"issue":"3","key":"80138_CR38","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","volume":"155","author":"S Sakaguchi","year":"1995","unstructured":"Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. & Toda, M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155(3), 1151\u20131164 (1995).","journal-title":"J. Immunol."},{"issue":"3","key":"80138_CR39","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.coi.2006.03.017","volume":"18","author":"LE Harrington","year":"2006","unstructured":"Harrington, L. E., Mangan, P. R. & Weaver, C. T. Expanding the effector CD4 T-cell repertoire: The Th17 lineage. Curr. Opin. Immunol. 18(3), 349\u2013356 (2006).","journal-title":"Curr. Opin. Immunol."},{"key":"80138_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106877","volume":"88","author":"B Wang","year":"2020","unstructured":"Wang, B. et al. Role of T cells in the pathogenesis and treatment of gout. Int. Immunopharmacol. 88, 106877. https:\/\/doi.org\/10.1016\/j.intimp.2020.106877 (2020).","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"80138_CR41","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1182\/blood-2006-12-064527","volume":"110","author":"G Borsellino","year":"2007","unstructured":"Borsellino, G. et al. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: Hydrolysis of extracellular ATP and immune suppression. Blood 110(4), 1225\u20131232 (2007).","journal-title":"Blood"},{"issue":"15","key":"80138_CR42","doi-asserted-by":"publisher","first-page":"3679","DOI":"10.3390\/cancers14153679","volume":"14","author":"C Martinez-Gomez","year":"2022","unstructured":"Martinez-Gomez, C. et al. Circulating exhausted PD-1+CD39+ helper CD4 T cells are tumor-antigen-specific and predict response to PD-1\/PD-L1 axis blockade. Cancers 14(15), 3679. https:\/\/doi.org\/10.3390\/cancers14153679 (2022).","journal-title":"Cancers"},{"issue":"1","key":"80138_CR43","doi-asserted-by":"publisher","first-page":"2246319","DOI":"10.1080\/2162402X.2023.2246319","volume":"12","author":"SN Bossio","year":"2023","unstructured":"Bossio, S. N. et al. CD39+ conventional CD4+ T cells with exhaustion traits and cytotoxic potential infiltrate tumors and expand upon CTLA-4 blockade. Oncoimmunology 12(1), 2246319. https:\/\/doi.org\/10.1080\/2162402X.2023.2246319 (2023).","journal-title":"Oncoimmunology"},{"issue":"11","key":"80138_CR44","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.3390\/cells11111844","volume":"11","author":"A Kandel","year":"2022","unstructured":"Kandel, A., Li, L., Hada, A. & Xiao, Z. Differential expression of CD45RO and CD45RA in bovine T cells. Cells 11(11), 1844. https:\/\/doi.org\/10.3390\/cells11111844 (2022).","journal-title":"Cells"},{"issue":"7","key":"80138_CR45","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.it.2009.03.013","volume":"30","author":"N-P Weng","year":"2009","unstructured":"Weng, N.-P., Akbar, A. N. & Goronzy, J. CD28(-) T cells: Their role in the age-associated decline of immune function. Trends Immunol. 30(7), 306\u2013312. https:\/\/doi.org\/10.1016\/j.it.2009.03.013 (2009).","journal-title":"Trends Immunol."},{"issue":"8","key":"80138_CR46","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.it.2016.06.004","volume":"37","author":"M Seyda","year":"2016","unstructured":"Seyda, M., Elkhal, A., Quante, M., Falk, C. S. & Tullius, S. G. T cells going innate. Trends Immunol. 37(8), 546\u2013556. https:\/\/doi.org\/10.1016\/j.it.2016.06.004 (2016).","journal-title":"Trends Immunol."},{"issue":"3","key":"80138_CR47","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1046\/j.1365-2567.2001.01243.x","volume":"103","author":"YB Sullivan","year":"2001","unstructured":"Sullivan, Y. B., Landay, A. L., Zack, J. A., Kitchen, S. G. & Al-Harthi, L. Upregulation of CD4 on CD8+ T cells: CD4dimCD8bright T cells constitute an activated phenotype of CD8+ T cells. Immunology 103(3), 270\u2013280 (2001).","journal-title":"Immunology"},{"issue":"6","key":"80138_CR48","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1182\/blood-2002-07-1972","volume":"102","author":"A Zloza","year":"2003","unstructured":"Zloza, A., Sullivan, Y. B., Connick, E., Landay, A. L. & Al-Harthi, L. CD8+ T cells that express CD4 on their surface (CD4dimCD8bright T cells) recognize an antigen-specific target, are detected in vivo, and can be productively infected by T-tropic HIV. Blood 102(6), 2156\u20132164 (2003).","journal-title":"Blood"},{"issue":"1","key":"80138_CR49","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1365-2567.2011.03470.x","volume":"134","author":"M Strioga","year":"2011","unstructured":"Strioga, M., Pasukoniene, V. & Characiejus, D. CD8+ CD28- and CD8+ CD57+ T cells and their role in health and disease. Immunology 134(1), 17\u201332. https:\/\/doi.org\/10.1111\/j.1365-2567.2011.03470.x (2011).","journal-title":"Immunology"},{"key":"80138_CR50","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3389\/fimmu.2016.00665","volume":"7","author":"FA Arosa","year":"2016","unstructured":"Arosa, F. A., Esgalhado, A. J., Padr\u00e3o, C. A. & Cardoso, E. M. Divide, conquer, and sense: CD8+CD28- T cells in perspective. Front. Immunol. 7, 665. https:\/\/doi.org\/10.3389\/fimmu.2016.00665 (2016).","journal-title":"Front. Immunol."},{"issue":"6","key":"80138_CR51","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1093\/intimm\/10.6.775","volume":"10","author":"Z Liu","year":"1998","unstructured":"Liu, Z., Tugulea, S., Cortesini, R. & Suciu-Foca, N. Specific suppression of T helper alloreactivity by allo-MHC class I-restricted CD8+CD28- T cells. Int. Immunol. 10(6), 775\u2013783 (1998).","journal-title":"Int. Immunol."},{"issue":"6","key":"80138_CR52","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/cmi.2014.118","volume":"12","author":"Q Liu","year":"2015","unstructured":"Liu, Q. et al. Human mesenchymal stromal cells enhance the immunomodulatory function of CD8(+)CD28(-) regulatory T cells. Cell Mol. Immunol. 12(6), 708\u2013718. https:\/\/doi.org\/10.1038\/cmi.2014.118 (2015).","journal-title":"Cell Mol. Immunol."},{"key":"80138_CR53","doi-asserted-by":"publisher","first-page":"8941260","DOI":"10.1155\/2016\/8941260","volume":"2016","author":"J Reiser","year":"2016","unstructured":"Reiser, J. & Banerjee, A. Effector, memory, and dysfunctional CD8(+) T cell fates in the antitumor immune response. J. Immunol. Res. 2016, 8941260. https:\/\/doi.org\/10.1155\/2016\/8941260 (2016).","journal-title":"J. Immunol. Res."},{"issue":"1","key":"80138_CR54","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4103\/2321-3868.126086","volume":"2","author":"J Su","year":"2014","unstructured":"Su, J., Xie, Q., Xu, Y., Li, X. C. & Dai, Z. Role of CD8(+) regulatory T cells in organ transplantation. Burns Trauma 2(1), 18\u201323. https:\/\/doi.org\/10.4103\/2321-3868.126086 (2014).","journal-title":"Burns Trauma"},{"key":"80138_CR55","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fimmu.2017.00031","volume":"8","author":"Y Vuddamalay","year":"2017","unstructured":"Vuddamalay, Y. & van Meerwijk, J. P. M. CD28- and CD28lowCD8+ regulatory T cells: Of mice and men. Front. Immunol. 8, 31. https:\/\/doi.org\/10.3389\/fimmu.2017.00031 (2017).","journal-title":"Front. Immunol."},{"issue":"7","key":"80138_CR56","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1182\/blood-2004-07-2583","volume":"105","author":"K Fischer","year":"2005","unstructured":"Fischer, K. et al. Isolation and characterization of human antigen-specific TCR alpha beta+ CD4(-)CD8- double-negative regulatory T cells. Blood 105(7), 2828\u20132835 (2005).","journal-title":"Blood"},{"issue":"2","key":"80138_CR57","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1189\/jlb.3RU0914-443R","volume":"97","author":"S Paul","year":"2015","unstructured":"Paul, S. Shilpi, and Lal G, role of gamma-delta (\u03b3\u03b4) T cells in autoimmunity. J. Leukoc. Biol. 97(2), 259\u2013271. https:\/\/doi.org\/10.1189\/jlb.3RU0914-443R (2015).","journal-title":"J. Leukoc. Biol."},{"issue":"10","key":"80138_CR58","doi-asserted-by":"publisher","first-page":"5791","DOI":"10.4049\/jimmunol.1000362","volume":"184","author":"SC Cowley","year":"2010","unstructured":"Cowley, S. C., Meierovics, A. I., Frelinger, J. A., Iwakura, Y. & Elkins, K. L. Lung CD4-CD8- double-negative T cells are prominent producers of IL-17A and IFN-gamma during primary respiratory murine infection with Francisella tularensis live vaccine strain. J. Immunol. 184(10), 5791\u20135801. https:\/\/doi.org\/10.4049\/jimmunol.1000362 (2010).","journal-title":"J. Immunol."},{"issue":"9","key":"80138_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004396","volume":"10","author":"Z Mou","year":"2014","unstructured":"Mou, Z. et al. MHC class II restricted innate-like double negative T cells contribute to optimal primary and secondary immunity to Leishmania major. PLoS Pathog. 10(9), e1004396. https:\/\/doi.org\/10.1371\/journal.ppat.1004396 (2014).","journal-title":"PLoS Pathog."},{"issue":"5127","key":"80138_CR60","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1126\/science.8367726","volume":"261","author":"RM Locksley","year":"1993","unstructured":"Locksley, R. M., Reiner, S. L., Hatam, F., Littman, D. R. & Killeen, N. Helper T cells without CD4: Control of leishmaniasis in CD4-deficient mice. Science (New York, N.Y.) 261(5127), 1448\u20131451 (1993).","journal-title":"Science (New York, N.Y.)"},{"issue":"6","key":"80138_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003441","volume":"9","author":"V Sundaravaradan","year":"2013","unstructured":"Sundaravaradan, V. et al. Multifunctional double-negative T cells in sooty mangabeys mediate T-helper functions irrespective of SIV infection. PLoS Pathog. 9(6), e1003441. https:\/\/doi.org\/10.1371\/journal.ppat.1003441 (2013).","journal-title":"PLoS Pathog."},{"issue":"1","key":"80138_CR62","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1038\/s41467-020-16636-4","volume":"11","author":"H Li","year":"2020","unstructured":"Li, H. et al. Systemic lupus erythematosus favors the generation of IL-17 producing double negative T cells. Nat. Commun. 11(1), 2859. https:\/\/doi.org\/10.1038\/s41467-020-16636-4 (2020).","journal-title":"Nat. Commun."},{"issue":"1","key":"80138_CR63","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1006\/clim.2002.5225","volume":"104","author":"JJH Bleesing","year":"2002","unstructured":"Bleesing, J. J. H. et al. A composite picture of TcR alpha\/beta(+) CD4(-)CD8(-) T cells (alpha\/beta-DNTCs) in humans with autoimmune lymphoproliferative syndrome. Clin. Immunol. 104(1), 21\u201330 (2002).","journal-title":"Clin. Immunol."},{"issue":"12","key":"80138_CR64","doi-asserted-by":"publisher","first-page":"8761","DOI":"10.4049\/jimmunol.181.12.8761","volume":"181","author":"JC Crisp\u00edn","year":"2008","unstructured":"Crisp\u00edn, J. C. et al. Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J. Immunol. 181(12), 8761\u20138766 (2008).","journal-title":"J. Immunol."},{"issue":"1","key":"80138_CR65","doi-asserted-by":"publisher","first-page":"103","DOI":"10.4049\/jimmunol.143.1.103","volume":"143","author":"S Shivakumar","year":"1989","unstructured":"Shivakumar, S., Tsokos, G. C. & Datta, S. K. T cell receptor alpha\/beta expressing double-negative (CD4-\/CD8-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis. J. Immunol. 143(1), 103\u2013112 (1989).","journal-title":"J. Immunol."},{"issue":"12","key":"80138_CR66","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1002\/eji.1830211215","volume":"21","author":"CT Morita","year":"1991","unstructured":"Morita, C. T. et al. Functionally distinct subsets of human gamma\/delta T cells. Eur. J. Immunol. 21(12), 2999\u20133007 (1991).","journal-title":"Eur. J. Immunol."},{"issue":"12","key":"80138_CR67","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1136\/annrheumdis-2016-211069","volume":"76","author":"W-X Mo","year":"2017","unstructured":"Mo, W.-X. et al. Chemotaxis of V\u03b42 T cells to the joints contributes to the pathogenesis of rheumatoid arthritis. Ann. Rheum. Dis. 76(12), 2075\u20132084. https:\/\/doi.org\/10.1136\/annrheumdis-2016-211069 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"80138_CR68","doi-asserted-by":"publisher","first-page":"721","DOI":"10.2147\/JIR.S449329","volume":"17","author":"H Di","year":"2024","unstructured":"Di, H., Han, X., Yin, Y., Zhang, Y. & Zeng, X. Role of chemotaxis of V\u03b42 T cells to the synovium in the pathogenesis of acute gouty arthritis. J. Inflamm. Res. 17, 721\u2013736. https:\/\/doi.org\/10.2147\/JIR.S449329 (2024).","journal-title":"J. Inflamm. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80138-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80138-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80138-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T12:07:26Z","timestamp":1733227646000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80138-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,3]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["80138"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-80138-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,3]]},"assertion":[{"value":"12 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical review and approval were not required for the study on human participants in accordance with the local legislation and institutional requirements. Written informed consent from the participant\u2019s legal guardian\/next of kin was not required to participate in this study in accordance with the national legislation and institutional requirements.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"30070"}}